Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Pennsylvania guidePennsylvania Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Pennsylvania
  4. ›Healthcare and Medical Services
  5. ›QQ - Naloxone & Mucosal Atomization Device

Awarded contract·County of Lehigh·Pennsylvania

QQ - Naloxone & Mucosal Atomization Device

Won by McKesson Medical-Surgical Government Solutions LLC$4kSingle Award
Contract source

Awarded vendors

  • McKesson Medical-Surgical Government Solutions LLC

Description

The County of Lehigh posted a bid for Naloxone and Mucosal Atomization Devices. The contract was awarded to McKesson Medical-Surgical Government Solutions LLC. The devices are to be delivered to various locations, including Cetronia Ambulance Corp and Allentown EMS for Allentown Police Dept. The bid includes 100 doses of Naloxone and 125 Mucosal Atomization Devices. The key points of this contract are: • The contract is for the supply of Naloxone and Mucosal Atomization Devices. • The devices are to be delivered to various locations in Allentown, PA. • The contract was awarded to McKesson Medical-Surgical Government Solutions LLC. • The bid includes 100 doses of Naloxone and 125 Mucosal Atomization Devices. • The contract does not specify a start or end date, but the bid posting and submission dates are Aug 9, 2017, and Aug 11, 2017, respectively.

Attached files

Key dates

Last updated

Details

Award type
Single Award
Procurement
Full and Open Competition
Industry
Healthcare and Medical Services
NAICS
339112
Solicitation №
QQ - Naloxone & Mucosal Atomization Device, BidId: 83303

Contract value

$4,137

Based on the final tabulation sheet, the contract value is likely to be around $4,137.50, which is the quote total from the awarded vendor, McKesson Medical-Surgical Government Solutions LLC. However, this is just an estimate, and the actual contract value may be different. Factors that may influence the contract value include the quantity of devices, delivery costs, and any additional services or support required.

AI estimate from the award documents

Similar open opportunities

Matched by Bid Banana AI™

New Jersey Division of Purchase and Property·New Jersey

Top match · 63%

T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services

Closes 12/4/2026Opened 8/19/2026

U.S. Department Of Energy·New Mexico

63% match

TIDAL: Target-Induced Droplet Assembly of Ligands

Closes 12/8/2026Opened 9/8/2026

U.S. Department Of Defense·Pennsylvania

63% match

Epinephrine Injector

Closes 11/2/2026Opened 4/29/2026

U.S. Department Of Energy·Ohio

63% match

TECHNOLOGY LICENSING OPPORTUNITY: SiloGetter

Closes 3/1/2027Opened 8/17/2026

U.S. Department Of Health And Human Services·United States of America

63% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. Department Of Defense·Massachusetts

62% match

Individual Water Treatment Device (IWTD) for Reduction/Removal of Toxic Industrial Chemicals and Materials

Closes 11/12/2026Opened 10/8/2026

U.S. Department Of Defense·United States of America

62% match

42--FACEPIECE,BREATHING EQ

Closes 11/4/2026Opened 10/25/2026

U.S. Department Of Energy·Ohio

62% match

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Closes 12/3/2026Opened 6/4/2026

U.S. Department Of Veterans Affairs·Nebraska

62% match

J045--Glycol Loop Flushing - NWI

Closes 11/10/2026Opened 10/14/2026

U.S. Department Of Energy·New Mexico

62% match

TECHNOLOGY LICENSING OPPORTUNITY: SiloGetter

Closes 3/1/2027Opened 8/17/2026

City of Philadelphia·Pennsylvania

62% match

1 Qt. Graffiti Remover

Closes 11/2/2026Opened 10/19/2026

NYS Roswell Park Cancer Institute Corp.·New York

62% match

Bulk Medical Gas

Closes 11/16/2026Opened 10/23/2026

U.S. Department Of Defense·United States of America

62% match

Morphine Sulfate Solution

Closes 12/21/2026Opened 9/21/2026

U.S. Department Of Energy·Ohio

62% match

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

Closes 12/15/2026Opened 6/15/2026

U.S. National Institutes of Health·United States of America

62% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. Department Of Defense·Virginia

62% match

Atomically Precise Molecules (APM)

Closes 12/18/2026Opened 10/8/2026

U.S. Department Of Defense·North Carolina

61% match

Omega-3 Acid Ethyl Esters

Closes 12/30/2029Opened 2/9/2023

U.S. Department Of Defense·United States of America

61% match

36--CHLORINATOR, ECG

Closes 12/10/2026Opened 10/27/2026

City of Mobile·Alabama

61% match

DISPOSAL SERVICE FOR BLOOD CONTAMINATED MEDICAL PRODUCTS, SUPPLIES, AND SHARPS

Closes 11/20/2026Opened 10/27/2026

U.S. Department Of Defense·California

61% match

OCONUS Medical Q-Coded Services

Closes 4/19/2027Opened 2/23/2026

U.S. Food and Drug Administration·United States of America

61% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

West Virginia Division of Natural Resources – Wildlife Resources Section·West Virginia

61% match

WRS: Open-End Contract for Formaldehyde

Closes 11/17/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

61% match

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closes 11/18/2027Opened 11/20/2024

U.S. Food and Drug Administration·United States of America

61% match

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Rolling / TBD closeOpened 8/14/2024

LA General Services·California

61% match

ANTISCALANT (PRETREAT PLUS 0100), MFR. KING LEE TECHNOLOGIES

Closes 11/5/2026Opened 10/30/2026